Differentiated somatic cells of various species can be reprogrammed into induced pluripotent stem cells (iPSCs) by ectopically expressing a combination of several transcription factors that are highly enriched in embryonic stem cells (ESCs). The generation of iPSCs in large animals has raised the possibility of producing genetically modified large animals through the nuclear transplantation approach. However, it remains unknown whether iPSCs could be used for generating cloned animals through the nuclear transfer method. Here, we show the successful production of viable cloned mice from inducible iPSCs through the nuclear transfer approach, and the efficiency is similar to that of using ESCs derived via normal fertilization. Furthermore, the cloned mice are fertile and can produce second-generation offspring. These efforts strengthen the possibility of utilizing iPSCs to generate gene-modified large animals for pharmaceutical purposes in the future.
INTRODUCTION
Recent advances in cell reprogramming have clearly indicated that differentiated somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) that are fully pluripotent by ectopically expressing the POU5F1, SOX2, KLF4, and MYC transcription factors [1] [2] [3] [4] [5] [6] [7] . Moreover, patient-specific iPSCs have been successfully derived and are proposed as a potential application in the treatment of various diseases or as an in vitro system to screen appropriate drug targets for specific individuals [8] [9] [10] [11] .
More recently, iPSCs have been successfully generated in several other species, including the rhesus monkey, rat, and mini-pig [12] [13] [14] [15] [16] [17] . Subsequently, the generation of gene knockout or knock-in large animals through the transfer of genetically modified iPSC nuclei into enucleated oocytes has been proposed. This method will potentially circumvent the fact that no bona fide embryonic stem cells (ESCs) are available in large animals for gene targeting [18] . Although a few reports have indicated that somatic cell nuclear transfer (SCNT) can be used to generate gene-targeted large animals [19] [20] , site-specific gene targeting in somatic cells has been proven rather inefficient. If the iPSCs created in large animals can be used to generate cloned animals by the nuclear transfer method, it will dramatically shorten the experimental timescale and increase the ease of generating gene-targeted large animals. In the present study, we provide evidence showing that viable and fertile mice can be directly produced from doxycyclineinducible iPSCs through the nuclear transfer approach, and our results highlight a possible method for potentially utilizing iPSCs to generate gene-modified large animals for pharmaceutical purposes in the future.
MATERIALS AND METHODS

Mice and Cell Culture
Female B6D2F 1 (C57BL/63DBA/2) mice (8-10 wk old; Vital River) were superovulated by the sequential injection of 7 IU each of serum gonadotropin and human chorionic gonadotropin (Sigma-Aldrich). Metaphase II (MII) oocytes were then collected for nuclear transplantation experiments. To generate iPSCs, mouse embryonic fibroblast cells (MEFs) were derived from 13.5 days postcoitum (dpc) embryos collected from the female 129/SV mice mated with Rosa26-M2rtTA mice (official symbol Gt(ROSA)26Sor tm1(rtTA*M2)Jae . ESCs derived from normal fertilization and iPSCs were cultured on mitomycin Ctreated MEFs in ESC medium (Dulbecco modified Eagle medium with 15% fetal bovine serum, leukemia-inhibiting factor, L-glutamine, b-mercaptoethanol, nucleotides, and nonessential amino acid).
All studies adhered to procedures consistent with the National Institute of Biological Sciences Guide for the Care and Use of Laboratory Animals.
Plasmid and iPSC Generation
LV-tetO-Oct4 (POU5F1), SOX2, KLF4, and c-Myc (MYC) were generously provided by Dr. Rudolf Jaenisch's laboratory at Whitehead Institute for Biomedical Research. Inducible iPSCs were generated as previously described [5, [21] [22] . Briefly, 293T cells were transfected with the LV-tetO vectors together with packaging plasmids psPAX2 and pMD2.G. The medium was replaced 12 h after transfection, and the virus supernatants were harvested 24 h subsequently. MEFs at passage 2 or 3 in 60-mm dishes at a density of ;5 3 10 5 cells/dish were incubated with filtrated viral supernatants containing 5 lg/ml polybrene. The infection medium was replaced after 12 h with ES medium supplemented with 1 lg/ml doxycycline. The medium was replaced every day until the ESC-like colonies appeared at around 12 days after infection. The cells were cultured for another 4 days with ES medium, and then the colonies were picked.
Genomic PCR, Simple Sequence Length Polymorphism, and Karyotyping
Genomic DNA was isolated from the indicated tissues with phenol:chloroform:isoamyl alcohol (25:24:1) using standard protocol. Transgene rtTA and simple sequence length polymorphism (SSLP) were used to identify the origin of cells and mice. SSLP analyses were performed for D6Mit15 and D4Mit204. The PCR primers sequences for rtTA and SSLP were obtained from the Mouse Genome Informatics website (The Jackson Laboratory, http://www.informatics. jax.org). Chromosomal G-band analyses were performed for karyotyping.
RT-PCR and qPCR Analyses of Marker Genes
Total RNA of cells was purified with Trizol reagent (Invitrogen), and total RNA of iPSC-cloned embryos was purified with PicoPure RNA Isolation Kit (Molecular Devices), then reverse transcription was performed using a reverse transcription system (Promega) according to the manufacturer's recommendations. Real-time PCR was performed using a SYBR Green-based PCR Master Mix (ABI) and signals were detected with the ABI7500 Real-Time PCR System (Applied Biosystems). The primer design was performed as previously described [1] . GAPDH was used as endogenous control. Examination for exogenous factor expression was performed with primers as follows:
Immunofluorescence Staining
To investigate the protein expression of transcription factors POU5F1, SOX2, and NANOG and ESC surface marker FUT4 (SSEA1) in iPSCs, iPSCs grown on the gelatin-coated cover slides were fixed in 4% paraformaldehyde. After permeabilization with 0.1% Triton-X and blocking with 10% NGS, the cells were incubated with the primary antibodies against OCT4 (POU5F1; Santa Cruz), SOX2 (Abcam), NANOG (Cosmo BioCo., Ltd.), and SSEA1 FUT4 (SSEA1; Abcam). The samples were incubated with appropriate secondary antibodies after being washed three times. DNA was labeled by 4 0 ,6-diamidino-2-phenylindole (DAPI; Molecular Probes). Stained cells mounted on slides were observed on an LSM 510 META microscope (Zeiss) using Plan Neofluar 633/1.4 Oil DIC objective.
To investigate the microtubule organization in iPSC-reconstructed oocytes and the expression of POU5F1 and CDX2 in the iPSC-cloned embryos, the iPSC-reconstructed oocytes, iPSC-cloned embryos, and control oocytes and embryos were fixed in 4% paraformaldehyde in PBS for 1 h at room temperature and then permeabilized with 1% Triton X-100 in PBS for 20 min. Then, all the samples were incubated in a blocking solution (5% bovine serum albumin in PBS) for at least 2 h at 378C. Immunocytochemistry staining was performed by incubating the fixed samples with primary antibodies against atubulin (Sigma), OCT4 (POU5F1; Santa Cruz), and CDX2 (Biogenex) for 2 h at 378C or overnight at room temperature, washing three times in PBS, and then incubating with appropriate secondary antibodies for 1 h at 378C in the dark. The secondary antibodies used included Alexa Fluor 594 goat anti-mouse and Alexa Fluor 488 goat anti-mouse. After being washed, DNA was labeled by 500 ng/ml of DAPI. Finally, all the samples were mounted on slides in antifade solution. The mounted slides were observed on an LSM 510 META confocal microscope using Plan Neofluar 633/1.4 Oil DIC objective; the excitation wavelengths used were 543, 488, and 405 nm.
Tetraploid Complementation
To perform tetraploid blastocyst complementation, tetraploid embryos were first produced by the electrofusion of two-cell stage embryos collected from mated female B6D2F1 mice or ICR mice. About 10-15 iPSCs were subsequently injected into the cavity of tetraploid blastocysts assisted by a piezo-drill micromanipulator. The tetraploid-complemented embryos were cultured in potassium simplex optimized medium (KSOM) for 2-3 h and then transplanted into the oviducts of pseudopregnant mice. Cesarean section was carried out at Day 19.5, and pups were fostered to lactating C57BL/6 mothers.
Nuclear Transfer
To generate diploid cloned constructs by SCNT using iPSCs as donor nuclei, spindle-chromosome complexes (SCC) of MII-arrested oocytes were first removed. After SCC removal, oocytes were kept in Chatot, Ziomek, and Bavister medium with glucose (CZBG) medium until injection. Then small iPSCs, which were presumably at G1 stage, were selected. The iPSC nucleus was then separated and injected into the enucleated oocyte using a piezo-drill micromanipulator. After injection of the iPSC nucleus, the cloned constructs were allowed to recover for several minutes before transfer back to CZBG medium. Reconstructed oocytes were cultured in CZBG medium for approximately 1-3 h before activation. Then activation was achieved by 6 h of culture of cloned constructs in calcium-free CZBG medium containing 10 mM of strontium chloride and 5 lg/ml of cytochalasin B (CB). Activated constructs were thoroughly washed and cultured in G1 and G2 medium (Vitrolife). To generate iPSC-cloned constructs using the M-phase iPSCs, the iPSCs were first cultured in medium containing 0.05 lg/ml demecolcine for 8 h to arrest at M phase. Then the M-phase iPSC chromosomes were transferred into the enucleated MII oocytes using a pipette with a relatively larger inner diameter assisted by a piezo-drill micromanipulator. To activate the cloned constructs reconstituted with M-phase iPSCs, the cloned constructs were cultured in calcium-free Chatot, Ziomek, and Bavister (CZB) medium containing 10 mM of strontium but without CB for 5-6 h.
RESULTS
Derivation of Inducible iPSCs with Full Pluripotency
To investigate whether iPSCs are capable of generating cloned animals, we first derived more than 20 inducible iPSC lines by infecting fibroblast cells from (129/SV3 Rosa26-M2rtTA)F1 fetal mice with doxycycline-inducible lentiviral vectors encoding the POU5F1, SOX2, KLF4, and MYC transcription factors [5, [21] [22] . These inducible iPSC lines resemble fertilization-derived ESCs morphologically, and the reactivation of endogenous pluripotency genes and simultaneous silencing of the exogenous factors were detected after the removal of doxycycline from the culture medium (Fig. 1A and Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org). The expression of the other pluripotency genes was detected in the tested iPSC lines (Fig.  1A) . Protein expression of the three important pluripotency genes Pou5f1, Sox2, and Nanog and the mouse ESC surface marker Fut4 was observed in the iPSCs (Fig. 1B) . Moreover, seven iPSC lines were found to be fully pluripotent because full-term mice were produced through the tetraploid blastocyst complementation assay (Table 1) . One specific iPSC line, LiPS-37, produced full-term mice with an efficiency comparable to that of normal ESCs. Moreover, these mice that were generated survived normally to adulthood and generated second-generation offspring (Fig. 1, C and D) . All of these findings demonstrated that these iPSC lines with a hybrid genetic background were fully pluripotent, which is consistent with our recent findings [5] .
Preimplantation Development of Cloned Embryos Reconstructed with iPSCs
To further investigate whether the fully pluripotent iPSCs could produce cloned animals after transplantation into enucleated metaphase II (MII) oocytes, we performed nuclear transfer experiments as previously described [23] [24] [25] . First, we transferred iPSC (LiPS-37) nuclei presumably at the G1 stage into enucleated B6D2F1 (C57BL/63DBA/2) MII oocytes with the piezo-drill micromanipulator (PMM-150). After the iPSC nuclear-transferred oocytes were activated with calcium-free CZB medium supplemented with 10 mM strontium chloride and 5 lg/ml CB for 5-6 h, a low percentage of cloned embryos developed to the morulae/blastocyst stage (Supplemental Table  S1 ). Such poor embryo development may be caused by the fact that very few iPSCs remain at the G1 stage in the normal culture medium and thus we failed to retrieve the donor cells in a homogenous cell cycle stage.
To overcome this obstacle, we synchronized the cell cycle of iPSCs at the M phase by treating the cells with 0.05 lg/ml of demecolcine for 8 h. Next, we transferred the M-phase iPSCs (the cell membrane was broken by a single piezo pulse) into enucleated MII oocytes using a pipette with a relatively larger inner diameter. One hour after injection of M-phase chromosomes into the enucleated MII oocyte, a well-formed spindle was observed in the oocyte ( Fig. 2A and Supplemental Fig.  S2 ). The reconstructed oocytes were then activated with calcium-free CZB medium containing strontium but without CB, which resulted in pseudopolar bodies extruding during the activation treatment. Subsequently, one pseudopronucleus formed in each cloned embryo ( Fig. 2B and Supplemental  Fig. S3) .
Then, we cultured the cloned embryos reconstructed with M-phase iPSCs in G1/G2 culture medium (Vitrolife). In contrast to the cloned embryos reconstructed with G1-stage iPSCs, the cleavage of embryos reconstructed with M-phase MICE CLONED FROM INDUCED PLURIPOTENT STEM CELLS iPSCs was observed at much higher efficiency (Table 2 and  Supplemental Table S1 ). Subsequently, over 70% of cloned embryos developed to the morulae/blastocyst stage, which is significantly higher than the developmental efficiency of embryos reconstructed with G1-stage cells (Table 2 and  Supplemental Table S1 ). Importantly, the in vitro developmental efficiency of cloned embryos reconstituted with Mphase iPSCs showed no difference when compared to that of cloned embryos reconstructed with normal ESCs at the M phase ( Table 2 ). The morphology of cloned embryos at different stages appeared normal (Fig. 2C) , and the reactivation of POU5F1 expression in the cloned embryos was not different compared to embryos derived from normal fertilization (Supplemental Fig. S4 ). At the blastocyst stage, POU5F1 expression in the inner cell mass of iPSC-cloned embryos was observed (Fig. 2D) . Similar to normal embryos, the first cell fate determination occurred in iPSC-cloned embryos at the late eight-cell to early morulae stage, at which the expression of CDX2 in some blastomeres was detected (Supplemental Fig.   S5 ). At the blastocyst stage, expression of CDX2 in trophoblast cells in iPSC-cloned embryos was observed (Fig. 2E) , and this finding is the first evidence showing that iPSCs can be reprogrammed then differentiate into trophoblast lineages in vivo.
Unlike for somatic cell cloning, it needs to be determined whether exogenous factors can be reactivated by MII cytoplasm during the nuclear cloning process. Next, we studied the expression of the four exogenous factors at the two-cell and morulae/blastocyst stages of cloned embryos, and the results further indicated that no reactivation of these exogenous factors was observed during the preimplantation development of cloned embryos (Supplemental Fig. S6 ). However, expression of the exogenous factors could be detected when we treated the cloned embryos with doxycycline, and the preimplantation development of the cloned embryos was slightly reduced (Supplemental Table S2 and Supplemental Figs. S6 and S7 ). The present iPSCs utilized are inducible; therefore, it will be essential to further investigate whether exogenous factors in the   FIG. 1. Characterization of iPSCs. A) RT-PCR revealed that inducible iPSCs expressed ESC marker genes including Pou5f1, Sox2, Nanog, and other pluripotency-related genes. B) Immunofluorescent staining results demonstrated that the iPSCs were positive for POU5F1, SOX2, NANOG, and FUT4. Bars ¼ 20 lm. C) Two iPSC pups generated by tetraploid blastocyst complementation were named as ''iTwins,'' which were born from the same surrogate mother and grown into adults. D) The iPSC mice with agouti color could generate secondgeneration offspring.
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iPSCs produced by retroviral infection can be reactivated during the cloning process.
Generation of Cloned Mice from iPSCs
Finally, we sought to investigate whether iPSC-cloned embryos could develop to term in vivo. As shown in Table 2 , we transferred 317 cloned embryos at the morulae/blastocyst stage and 352 cloned embryos at the four-to eight-cell stage to recipient pseudopregnant female ICR mice, respectively. At 19.5 dpc, cesarean sections were performed, and 15 cloned pups were recovered ( Table 2, Fig. 3A , and Supplemental Table S3 ). The efficiency of generating cloned pups using iPSCs as donors is slightly lower than the efficiency when using normal ESCs (Table 2) . Moreover, six iPSC-cloned mice survived to adulthood and produced second-generation offspring, and the other nine cloned mice died either during the first day after cesarean section or because of rejection by the foster mother during feeding (Fig. 3, B and C) .
To further verify the genotype of the cloned mice, analyses of the rtTA transgene and microsatellite DNA were performed. As shown in Figure 3D , both the placentas and the tail tips of the five cloned mice contained the rtTA transgene, which is similar to the original iPSCs. Moreover, analyses of microsatellite DNA by SSLP showed that the genomes of both the placentas and the tail tips of the cloned mice were the same as the iPSCs but different from the oocyte donors' genomes (Fig.  3, E and F) . We next analyzed whether the fibroblast cells collected from the cloned pups could be reprogrammed by simply adding doxycycline to the culture medium. We determined that the somatic cells from the cloned mice were induced to pluripotency by adding doxycycline (Fig. 3G) . Therefore, similar to tetraploid-complemented mice, the cloned mice generated from inducible iPSCs provide an invaluable resource to further decipher the molecular mechanisms of somatic cell reprogramming. Finally, we propose that iPSCs generated in large animals such as pigs could be potentially utilized as appropriate seed cells for gene manipulation, and subsequently, the nuclear transfer method could be used for generating genetically modified large animals directly (Fig. 3H) .
DISCUSSION
Our present study provides definitive evidence showing that iPSCs can be used to produce cloned animals directly via the nuclear transfer approach. For the first time, we demonstrated that iPSCs can be reprogrammed into totipotent embryos by oocytes and then differentiate into all tissues, including both extraembryonic and embryonic tissues in vivo. Moreover, our study suggests that the iPSCs generated in large animals might be potentially applied to generate genetically modified large animals through nuclear transfer for pharmaceutical purposes.
It has been demonstrated previously that the cell cycle of donor cells plays an important role in supporting cloned embryo development, especially when ESCs are used as donor Five iPSC-cloned mice grew into adulthood (six mice survived, but one mouse was not old enough at the time the photograph was taken). C) The iPSC-cloned mice with agouti color could generate second-generation offspring. D) Genomic PCR analyzed the transgene, rtTA, in the placentas and the tail tips of the cloned mice. E, F) SSLP analyses of microsatellite DNA (D6Mit15 and D4Mit204) in the placentas and the tail tips of the cloned mice. G) Secondary iPSCs were produced from the fibroblast cells collected from the cloned mice by simply adding doxycycline in the culture medium. Original magnification 3100. H) Schematic of generating transgenic or knockout pigs by nuclear transfer using genetically modified iPSCs.
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cells. Improved development of cloned embryos could be achieved when ESCs are arrested at M phase [25] [26] [27] . Similar to ESCs, iPSCs used in the present study proliferate very fast, and very few iPSCs remain at the G1 stage in the normal culture medium. Subsequently, we proved that the cloned embryos reconstructed with iPSCs at M phase developed more efficiently. Therefore, our results suggest that iPSCs arrested at M phase might better serve as donor cells for cloning. Although recent studies have clearly shown that ESCs with germ line transmission capability have been successfully established in rat [28] [29] , it remains challenging to establish bona fide ESC lines in large animals. Consequently, no reliable gene targeting approach has been established in large animals. Currently, relatively highly efficient development of cloned embryos can be obtained in large animals such as cattle [30] , and then SCNT is normally used to generate gene-targeted large animals. However, site-specific gene targeting in somatic cells has been proven rather inefficient because of the limited cell proliferation property of somatic cells. Fortunately, iPSCs have been successfully derived from mini-pig somatic cells recently, although germ-line transmission is yet to be further defined [15] [16] [17] , which inspired us to apply iPSCs to generate gene-targeted large animals for pharmaceutical purposes.
In comparison with somatic cell cloning, iPSC cloning possesses two advantages. First, the efficiency of generating cloned animals through iPSC nuclear transfer appears greater than that of regular SCNT, because a recent study has indicated that treatment of SCNT-cloned embryos with histone deacetylase inhibitor could dramatically improve the development of SCNT-cloned embryos [31] . More importantly, iPSCs can be maintained in vitro without senescence, which allows gene manipulation to be performed easily with these cells in large animals. Therefore, our results suggest that iPSCs derived in large animals might potentially be suitable to be applied to generate genetically modified animals through the nuclear transfer method.
